PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28336808-2 2017 Using the chemical scaffold of the JAK2 inhibitor TG101348, we developed and characterized single agents which potently and simultaneously inhibit BRD4 and a specific set of oncogenic tyrosine kinases including JAK2, FLT3, RET, and ROS1. Fedratinib 50-58 ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens 232-236